Status:
COMPLETED
Study to Evaluate the Effects of Psyllium on Blood Glucose
Lead Sponsor:
Procter and Gamble
Conditions:
Healthy Men
Eligibility:
MALE
18-50 years
Phase:
NA
Brief Summary
This is an open label, single use, randomized, 4-period cross-over study. In each period, subjects will receive one of 4 test combinations. Blood will be drawn prior to study product consumption and f...
Eligibility Criteria
Inclusion
- male
- 18 to 50 years of age
- general good health
- Body Mass Index (BMI) in the range of 18.5-29.9 kg/m2
- fasting plasma blood glucose \<126mg/dL
- not actively treated for high blood glucose
- willing and able to have blood drawn at multiple times during each 4 visits
Exclusion
- history of allergy or hypersensitivity to inhaled or ingested psyllium or meal ingredients
- Phenylketonuria (PKU)
- an eating disorder
- following special medical or weight-loss dietary restrictions
- taking dietary supplements or prescription medication for the purpose of weight loss/management
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00888602
Start Date
April 1 2009
End Date
May 1 2009
Last Update
December 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hill Top Research
Miamiville, Ohio, United States, 45147